Literature DB >> 34119079

Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.

Louis S Matza1, Katie D Stewart2, Andrew J Lloyd3, Donna Rowen4, John E Brazier4.   

Abstract

Health technology assessment agencies often prefer that utilities used to calculate quality-adjusted life years in cost-utility analyses (CUAs) are derived using standardized methods, such as generic preference-based measures completed by patients in clinical trials. However, there are situations when no standardized approach is feasible or appropriate for a specific medical condition or treatment that must be represented in a CUA. When this occurs, vignette-based methods are often used to estimate utilities. A vignette (sometimes called a "scenario," "health state description," "health state vignette," or "health state") is a description of a health state that is valued in a preference elicitation task to obtain a utility estimate. This method is sometimes the only feasible way to estimate utilities representing a concept that is important for a CUA. Consequently, vignette-based studies continue to be conducted and published, with the resulting utilities used in economic models to inform decision making about healthcare resource allocation. Despite the potential impact of vignette-based utilities on medical decision making, there is no published guidance or review of this methodology. This article provides recommendations for researchers, health technology assessment reviewers, and policymakers who may be deciding whether to use vignette-based methods, designing a vignette study, using vignette-based utilities in a CUA, or evaluating a CUA that includes vignette-based utilities. Recommendations are provided on: (A) when to use vignette-based utilities, (B) methods for developing vignettes, (C) valuing vignettes, (D) use of vignette-based utilities in models, and (E) limitations of vignette methods.
Copyright © 2021 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cost-utility analysis; health state utilities; health state vignettes; time trade-off; utility assessment; vignette-based methods

Mesh:

Year:  2021        PMID: 34119079     DOI: 10.1016/j.jval.2020.12.017

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  6 in total

Review 1.  Time trade-off health state utility values for depression: a systematic review and meta-analysis.

Authors:  Péter György Balázs; Dalma Erdősi; Antal Zemplényi; Valentin Brodszky
Journal:  Qual Life Res       Date:  2022-09-30       Impact factor: 3.440

2.  Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China.

Authors:  Phil McEwan; James Baker-Knight; Björg Ásbjörnsdóttir; Yunni Yi; Aimee Fox; Robin Wyn
Journal:  Eur J Health Econ       Date:  2022-05-08

3.  Does de-implementation of low-value care impact the patient-clinician relationship? A mixed methods study.

Authors:  Michelle S Rockwell; Kenan C Michaels; John W Epling
Journal:  BMC Health Serv Res       Date:  2022-01-06       Impact factor: 2.655

4.  Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States.

Authors:  Siu Hing Lo; Andrew Lloyd; Shuayb Elkhalifa; Zlatko Sisic; Floortje E van Nooten
Journal:  Pharmacoecon Open       Date:  2021-09-17

5.  Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.

Authors:  C Simone Sutherland; Pollyanna Hudson; Stephen Mitchell; Noman Paracha
Journal:  Pharmacoeconomics       Date:  2021-12-15       Impact factor: 4.981

6.  A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France.

Authors:  Adam B Smith; Andria Hanbury; Jennifer A Whitty; Igor Beitia Ortiz de Zarate; Florence Hammes; Gérard de Pouvourville; Katharina Buesch
Journal:  Patient Relat Outcome Meas       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.